Patents
Patents for C07D 257 - Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms (9,612)
12/2004
12/08/2004EP1484313A1 Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase
12/08/2004EP1482896A2 Aminoalkylphosphonates and related compounds as edg receptor agonists
12/08/2004EP1482895A2 Aminoalkylphosphonates and related compounds as edg receptor agonists
12/08/2004CN1553907A Tetrazoyl oxime derivative and agrochemical containing the same as active ingredient
12/08/2004CN1553903A Method of storing tetrazolium compound, stabilizer for use therein, and tetrazolium compound reagent solution stored by the method
12/07/2004US6828447 Therapeutic agent for use in the treatment of cardiovascular and inflammatory disorders
12/07/2004US6827927 Preparation of racemic mixture of gadolinium complex of 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetra(2-glutaric acid); acid refluxing solution containing RRRR and SSSS stereoisomers
12/07/2004CA2112331C Novel naphthalene derivatives
12/02/2004US20040242895 herbicides
12/02/2004US20040242692 4-(3-(2,6-Dimethoxybenzyloxy)phenyl)-4-oxobutyric acid or derivatives for treatment of insulin resistance syndrome, diabetes, cachexia, hyperlipidemia, fatty liver disease, obesity, atherosclerosis or arteriosclerosis
12/02/2004US20040242661 Polymorphs of valsartan
12/02/2004US20040242631 PI-3 kinase inhibitor prodrugs
12/02/2004DE10320326A1 New 1-benzoyl-3-(heterocyclyl-phenyl)-urea derivatives, are glycogen phosphorylase a inhibitors useful e.g. for treating type II diabetes, dyslipidemia or arteriosclerosis
12/01/2004EP1481667A1 NEP inhibitors for the treatment of female sexual dysfunction
12/01/2004EP1481002A1 Histogranin-like peptides and non-peptides, processes for their preparation and uses thereof
12/01/2004EP1480979A2 Gadolinium chelate oligomers, their use as contrast products in magnetic resonance imaging and their synthesis intermediates
12/01/2004EP1480635A2 Macrocyclic module compositions
12/01/2004EP0977745B1 Thioaryl sulfonamide hydroxamic acid compounds
12/01/2004CN1550491A Novel delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides
11/2004
11/25/2004WO2004101535A1 Pharmaceutical composition comprising valsartan
11/25/2004WO2004101534A1 A METHOD OF PREPARATION OF N-(1-OXOPENTYL)-N-[[2'-(1H-TETRAZOL-5-y1) [1,1'-BIPHENYL] -4-y1]METHYL]-L-VALINE (VALSARTAN)
11/25/2004WO2004018386A3 Acetophenone potentiators of metabotropic glutamate receptors
11/25/2004US20040236100 For therapy of insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis
11/25/2004US20040235877 Novel use of tricyclic compound
11/25/2004US20040235814 Administering compounds such as 1-[1-methylene-4-(bromo-methylene)phenylene]-4,8,11-tris(diethoxyphosphoryl-1,4,8,11-tetraazacyclotetra-decane to modulate a chemokine receptor
11/25/2004CA2525665A1 Pharmaceutical composition comprising valsartan
11/25/2004CA2525653A1 A method of preparation of n-(1-oxopentyl)-n-[[2'-(1h-tetrazol-5-y1)[1, 1'-biphenyl]-4-y1]methyl]-l-valine (valsartan)
11/23/2004US6821960 Glucagon antagonists/inverse agonists
11/18/2004WO2004099134A2 Glutaminyl based dp iv-inhibitors
11/18/2004WO2004098591A2 Inhibitors of glutaminyl cyclase and their use in the treatment of neurological diseases
11/18/2004US20040229848 For therapy of non-insulin dependent diabetes
11/18/2004US20040226639 Propellant for gas generators
11/18/2004DE10307759B3 Trimere makrocyclisch substituierte Benzolderivate, deren Herstellung und Verwendung als Kontrastmittel sowie diese enthaltende pharmazeutische Mittel Trimeric macrocyclic substituted benzene derivatives, their preparation and use as a contrast agent, as well as pharmaceutical compositions containing them
11/17/2004EP1476437A1 Novel tetrazole derivative useful as herbicides
11/17/2004EP1476423A2 Arylsulfonamidobenzylic compounds
11/17/2004EP1476419A2 N-biphenylmethyl aminocycloalkanecarboxamide derivatives
11/17/2004EP1087953B1 Nitrate salts of antihypertensive medicines
11/16/2004CA2092306C Disubstituted aryl compounds exhibiting selective leukotriene b4 antagonist activity
11/11/2004WO2004056745A3 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors
11/11/2004US20040224875 Inhibitors of glutaminyl cyclase
11/10/2004EP1475371A1 1-substituted-1-aminomethyl-cycloalkane derivatives (= gabapentin analogues), their preparation and their use in the treatment of neurological disorders
11/10/2004EP1474402A1 Salts of valsartan
11/10/2004CN1544420A Inhibition of raf kinase using substituted heterocyclic ureas
11/04/2004WO2004094392A1 Process for the preparation of valsartan
11/04/2004WO2004094391A2 Process for the preparation of valsartan and intermediates thereof
11/04/2004WO2004080377A3 Kcnq channel modulating compounds and their pharmaceutical use
11/04/2004WO1999029693A8 Imidazonaphthyridines and their use in inducing cytokine biosynthesis
11/04/2004US20040220404 For therapy of obesity, diabetes, depression, or anxiety in a mammal
11/04/2004US20040220237 Asthma and allergic inflammation modulators
11/04/2004US20040220235 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits
11/04/2004US20040220148 5-Membered ring heterocycles as inhibitors of leucocyte adhesion and as VLA-4 antagonists
11/03/2004EP1317425B1 Resorcinol derivatives
11/03/2004CN1543452A 1,4-disubstituted benzenes as insecticides
11/03/2004CN1543451A Receptor modulators activated by peroxizonal proliferators (ppar)
11/03/2004CN1543311A Selective substituted aryl ketone and safener based herbicides
11/02/2004US6812237 (arylaminoaceamido)acetonitrile derivatives
10/2004
10/28/2004WO2004091724A1 Anthranilic acid derivatives useful in treating infection with hepatitis c virus
10/28/2004WO2004000826A8 Processes for producing epoxytriazole derivative and intermediate therefor
10/28/2004US20040214827 for the treatment and/or prevention of medical dysfunctions and diseases such as stroke, Parkinson's disease, and Alzheimer's disease caused by reactive oxygen species and/or excess Zn ions; neuroprotectants
10/27/2004EP1471049A1 Novel thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof
10/27/2004EP0960108B1 Matrix metalloproteinase inhibitors
10/21/2004WO2004089925A1 Pi-3 kinase inhibitor prodrugs
10/21/2004WO2004089360A1 Polyamine compounds for treating chemokine receptor mediated diseases
10/21/2004WO2003097163A3 Using a selective inos inhibitor for the treatment of respiratory diseases and conditions
10/21/2004US20040210051 Inhibitors of binding between vascular cell adhesion molecules and cells expressing vla-4 integrin; antiinflammatory agents
10/21/2004US20040206940 Novel method of preparing nitrogen macrocycles
10/21/2004CA2521416A1 Polyamine compounds for treating chemokine receptor mediated diseases
10/21/2004CA2518916A1 Pi-3 kinase inhibitor prodrugs
10/20/2004EP0830136B1 New cryptophycins from synthesis
10/20/2004CN1171886C Process for producing carbostyril derivative
10/19/2004US6806365 N-alkanoylphenylalamine derivatives
10/14/2004WO2004087681A1 A novel amorphous form of valsartan
10/14/2004WO2004056727A3 Process of making chalcone derivatives
10/14/2004US20040204502 Such as 4-(4-(3-hydroxy-3-methyl-butane-1-sulfinylmethyl)-phenylmethanesulfinyl)-2 -methyl-butan1-ol for treating and preventing cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders
10/14/2004US20040204436 Imidazonaphthyridines
10/13/2004EP1466898A1 Beta-amyloid protein production/secretion inhibitors
10/13/2004EP1465861A1 Alpha-(n-sulphonamido)acetamide derivatives as beta-amyloid inhibitors
10/13/2004EP1465854A2 Chalcone derivatives and their use to treat diseases
10/13/2004CN1170813C N2 phenylamidine derivatives and fungicidal composition and use
10/12/2004US6803384 Diaminopropionic acid derivatives
10/07/2004WO2004084898A1 2-phenoxy- and 2-phenylsulfomamide derivatives with ccr3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders
10/07/2004US20040198982 such as (4S)-1-(3-bromophenyl)-N-cyanomethyl)-4-methyl-prolinamide; for treatment of osteoporosis
10/07/2004US20040198814 prevention , therapy of cardiovascular disorders, dyslipidemias, glucose metabolism, hypoglycemic agents; reduce fat concentration in meat; reduce cholesterol concentration in eggs
10/07/2004US20040197879 1,2,3,4-tetrazol-1-yl-L-alanine or 1,2,3,4-tetrazol-2-yl-L-alanine.
10/06/2004EP1464643A1 Method of storing tetrazolium compound, stabilizer for use therein, and tetrazolium compound reagent solution stored by the method
10/06/2004EP1463715A1 Novel glucagon antagonists
10/06/2004EP1463495A2 Agents and methods for treatment of cancer
09/2004
09/30/2004WO2004083192A1 Polymorphis of valsartan
09/30/2004WO2003072535A8 Substituted hydroxyethylamines
09/30/2004US20040192771 Cerdiovascular disorders; antilipemic agents; alzheimer's disease; anticancer agents; sepsis; thrombosis; hypotensive agents; kidney diseases; antiinflammatory agents
09/30/2004US20040192747 Substituted N-benzoyl-N'-(tetrazolylphenyl)-ureas and their use as pest control agents
09/30/2004CA2519490A1 Polymorphis of valsartan
09/29/2004EP1461323A2 Compounds for the treatment of metabolic disorders
09/29/2004EP1461038A1 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders
09/29/2004EP1159272B1 A process for the preparation of 1,4,7,10-tetraazacyclododecane
09/29/2004CN1533286A Macrocyclic metal complexes and use thereof for production of conjugates with biomolecules
09/29/2004CN1168709C Alpha-hydroxy, amino and fluoro derivatives of beta-sulphenyl hdyroxamic acids matrix metalloproteinase inhibitors
09/28/2004US6797716 Imidazonaphthyridines
09/23/2004WO2004080984A1 Insecticidal phthalamide derivatives
09/23/2004WO2004080947A1 Imino ether derivative compounds and drugs containing the compounds as the active ingredient
1 ... 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 ... 97